FRE.DE - Fresenius SE & Co. KGaA

XETRA - XETRA Delayed Price. Currency in EUR

Fresenius SE & Co. KGaA

Else-Kröner-Strasse 1
Bad Homburg vor der Höhe 61352
Germany
49 6172 608 0
http://www.fresenius.com

SectorHealthcare
IndustryMedical Care
Full Time Employees288,459

Key Executives

NameTitlePayExercisedYear Born
Mr. Stephan SturmCEO, Pres & Chairman of Management Board - Fresenius Management SE3.52MN/A1963
Ms. Rachel Clare EmpeyCFO & Member of Management Board - Fresenius Management SE1.64MN/A1976
Dr. Francesco De MeoMember of Management Board - Fresenius Management SE2.4MN/A1964
Dr. Jürgen GötzChief Legal & Compliance Officer & Labor Relations Director and Member of Management Board - GP1.72MN/A1964
Dr. Ernst WastlerMember of Management Board - Fresenius Management SE1.69MN/A1959
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs, including intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing of blood components, as well as in transfusion medicine. The Fresenius Helios segment operates 86 hospitals, 124 outpatient clinics, and 10 prevention centers. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Corporate Governance

Fresenius SE & Co. KGaA’s ISS Governance QualityScore as of July 29, 2019 is 9. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 1; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.